Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Imaging of contrast medium extravasation in anticoagulation-associated intracerebral hemorrhage with dual-energy computed tomography.

Won SY, Schlunk F, Dinkel J, Karatas H, Leung W, Hayakawa K, Lauer A, Steinmetz H, Lo EH, Foerch C, Gupta R.

Stroke. 2013 Oct;44(10):2883-90. doi: 10.1161/STROKEAHA.113.001224. Epub 2013 Aug 6.

2.

Does dabigatran increase the risk of delayed hematoma expansion in a rat model of collagenase-induced intracerebral hemorrhage?

Tanoue S, Inamasu J, Yamada M, Toyama H, Hirose Y.

J Stroke Cerebrovasc Dis. 2015 Feb;24(2):374-80. doi: 10.1016/j.jstrokecerebrovasdis.2014.09.010. Epub 2014 Nov 25.

PMID:
25444028
3.

Translational insights into traumatic brain injury occurring during dabigatran or warfarin anticoagulation.

Schaefer JH, Leung W, Wu L, Van Cott EM, Lok J, Whalen M, van Leyen K, Lauer A, van Ryn J, Lo EH, Foerch C.

J Cereb Blood Flow Metab. 2014 May;34(5):870-5. doi: 10.1038/jcbfm.2014.31. Epub 2014 Feb 19.

4.

Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage.

Lauer A, Cianchetti FA, Van Cott EM, Schlunk F, Schulz E, Pfeilschifter W, Steinmetz H, Schaffer CB, Lo EH, Foerch C.

Circulation. 2011 Oct 11;124(15):1654-62. doi: 10.1161/CIRCULATIONAHA.111.035972. Epub 2011 Sep 12.

5.

Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran.

Zhou W, Schwarting S, Illanes S, Liesz A, Middelhoff M, Zorn M, Bendszus M, Heiland S, van Ryn J, Veltkamp R.

Stroke. 2011 Dec;42(12):3594-9. doi: 10.1161/STROKEAHA.111.624650. Epub 2011 Oct 13.

6.

Idarucizumab Improves Outcome in Murine Brain Hemorrhage Related to Dabigatran.

Na SY, Mracsko E, van Ryn J, Veltkamp R.

Ann Neurol. 2015 Jul;78(1):137-41. doi: 10.1002/ana.24421.

PMID:
25899749
7.

Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhage.

Schlunk F, Van Cott EM, Hayakawa K, Pfeilschifter W, Lo EH, Foerch C.

Stroke. 2012 Jan;43(1):246-9. doi: 10.1161/STROKEAHA.111.629360. Epub 2011 Oct 13.

8.

Management of dabigatran-associated intracerebral and intraventricular hemorrhage: a case report.

Faust AC, Peterson EJ.

J Emerg Med. 2014 Apr;46(4):525-9. doi: 10.1016/j.jemermed.2013.11.097. Epub 2014 Feb 6.

PMID:
24508114
9.

Comparative effectiveness of hemostatic therapy in experimental warfarin-associated intracerebral hemorrhage.

Illanes S, Zhou W, Schwarting S, Heiland S, Veltkamp R.

Stroke. 2011 Jan;42(1):191-5. doi: 10.1161/STROKEAHA.110.593541. Epub 2010 Dec 2.

10.

Dabigatran-related intracerebral hemorrhage resulting in hematoma expansion.

Simonsen CZ, Steiner T, Tietze A, Damgaard D.

J Stroke Cerebrovasc Dis. 2014 Feb;23(2):e133-4. doi: 10.1016/j.jstrokecerebrovasdis.2013.08.011. Epub 2013 Oct 6.

PMID:
24103671
11.

Rapid reversal of anticoagulation reduces hemorrhage volume in a mouse model of warfarin-associated intracerebral hemorrhage.

Foerch C, Arai K, Van Cott EM, van Leyen K, Lo EH.

J Cereb Blood Flow Metab. 2009 May;29(5):1015-21. doi: 10.1038/jcbfm.2009.27. Epub 2009 Mar 25.

12.

Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.

Ho CW, Ho MH, Chan PH, Hai JJ, Cheung E, Yeung CY, Lau KK, Chan KH, Lau CP, Lip GY, Leung GK, Tse HF, Siu CW.

Stroke. 2015 Jan;46(1):23-30. doi: 10.1161/STROKEAHA.114.006476. Epub 2014 Nov 18.

13.

Dabigatran and its reversal with recombinant factor VIIa and prothrombin complex concentrate: a Sonoclot in vitro study.

Sølbeck S, Nilsson CU, Engström M, Ostrowski SR, Johansson PI.

Scand J Clin Lab Invest. 2014 Oct;74(7):591-8. doi: 10.3109/00365513.2014.921930. Epub 2014 Jun 9.

PMID:
24909158
14.

Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia.

Sun L, Zhou W, Ploen R, Zorn M, Veltkamp R.

Thromb Haemost. 2013 Jul;110(1):153-61. doi: 10.1160/TH12-12-0942. Epub 2013 Apr 25.

PMID:
23615682
15.

Risk of bleeding with dabigatran in atrial fibrillation.

Hernandez I, Baik SH, Piñera A, Zhang Y.

JAMA Intern Med. 2015 Jan;175(1):18-24. doi: 10.1001/jamainternmed.2014.5398.

PMID:
25365537
16.

Pharmacologic interventions for reversing the effects of oral anticoagulants.

Kalus JS.

Am J Health Syst Pharm. 2013 May 15;70(10 Suppl 1):S12-21. doi: 10.2146/ajhp130041.

PMID:
23640528
17.

Hemostatic therapy in experimental intracerebral hemorrhage associated with rivaroxaban.

Zhou W, Zorn M, Nawroth P, Bütehorn U, Perzborn E, Heitmeier S, Veltkamp R.

Stroke. 2013 Mar;44(3):771-8. doi: 10.1161/STROKEAHA.112.675231. Epub 2013 Jan 22.

18.

Dabigatran bleed risk with closed head injuries: are we prepared?

Parra MW, Zucker L, Johnson ES, Gullett D, Avila C, Wichner ZA, Kokaram CR.

J Neurosurg. 2013 Sep;119(3):760-5. doi: 10.3171/2013.3.JNS12503. Epub 2013 May 1.

PMID:
23634730
19.

Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis.

Hijazi Z, Hohnloser SH, Oldgren J, Andersson U, Connolly SJ, Eikelboom JW, Ezekowitz MD, Reilly PA, Siegbahn A, Yusuf S, Wallentin L.

Circulation. 2014 Mar 4;129(9):961-70. doi: 10.1161/CIRCULATIONAHA.113.003628. Epub 2013 Dec 9.

20.

Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.

Healey JS, Eikelboom J, Douketis J, Wallentin L, Oldgren J, Yang S, Themeles E, Heidbuchel H, Avezum A, Reilly P, Connolly SJ, Yusuf S, Ezekowitz M; RE-LY Investigators.

Circulation. 2012 Jul 17;126(3):343-8. doi: 10.1161/CIRCULATIONAHA.111.090464. Epub 2012 Jun 14. Erratum in: Circulation. 2012 Sep 4;126(10):e160. Heidbuchle, Hein [corrected to Heidbuchel, Hein].

Supplemental Content

Support Center